Brief: Aurinia Appoints Two New Board Directors With Experience In Biopharma Leadership, Commercial Strategy, M&A And Advancing Therapeutic Pipelines
21/08/2023 11:02
Aug 21 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O :
* AURINIA APPOINTS TWO NEW BOARD DIRECTORS WITH DEEP
EXPERIENCE IN
BIOPHARMA LEADERSHIP, COMMERCIAL STRATEGY, MERGERS AND
ACQUISITIONS AND ADVANCING THERAPEUTIC PIPELINES
* AURINIA APPOINTS TWO NEW BOARD DIRECTORS WITH DEEP
EXPERIENCE IN
BIOPHARMA LEADERSHIP, COMMERCIAL STRATEGY, MERGERS AND
ACQUISITIONS AND ADVANCING THERAPEUTIC PIPELINES
* AURINIA PHARMACEUTICALS INC - DANIEL G. BILLEN APPOINTED
CHAIR
OF BOARD OF DIRECTORS
Source text for Eikon: ID:nBw3g4H7Xa
Further company coverage: AUPH.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death